Sleep
Meta-analysisNovember 20, 2026

Melatonin May Provide Surprising Relief for Irritable Bowel Syndrome

1

The Summary

Researchers conducted a systematic review and meta-analysis of seven randomized, placebo-controlled trials involving 391 adults with irritable bowel syndrome (IBS). Compared to placebo, melatonin supplementation cut the risk of moderate-to-severe IBS symptoms nearly in half. It also significantly reduced pain frequency and improved bowel movement regularity, with only mild, infrequent adverse effects. However, melatonin did not produce statistically significant improvements in overall quality of life or global sleep quality across the pooled trials.

2

Why this is interesting

Most people know melatonin only as a nighttime hormone, but the digestive tract actually contains substantial melatonin receptors. Because IBS involves dysregulated gut-brain communication, targeting these pathways can calm visceral hypersensitivity. This review suggests melatonin improves digestive motility and visceral pain directly, rather than just helping people rest. For millions coping with frustrating IBS flare-ups, melatonin represents an accessible, well-tolerated complementary option worth discussing with a physician.